Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)
Sandoz Canada Inc.
The decision is reported
Meet the team